Eltenac

Eltenac

SCHEMBL145080

O=C(O)Cc1cscc1Nc1c(Cl)cccc1Cl

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.67
TTR P02766 3/20 0.67
PTGS1 P23219 3/20 0.67
CXCL8 P10145 3/20 0.67
ABCB11 O95342 2/20 0.67
NR1I3 Q14994 2/20 0.67
AKR1B10 O60218 1/20 0.67
UGT1A9 O60656 1/20 0.67
TRPA1 O75762 1/20 0.67
MT-CO2 P00403 1/20 0.67
ALB P02768 1/20 0.67
UGT1A6 P19224 1/20 0.67
UGT1A1 P22309 1/20 0.67
CXCR1 P25024 1/20 0.67
ADRA1A P35348 1/20 0.67
AGTR2 P50052 1/20 0.67
SLC22A6 Q4U2R8 1/20 0.67
NR1H4 Q96RI1 1/20 0.67
UGT1A7 Q9HAW7 1/20 0.67
UGT1A10 Q9HAW8 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eltenac SCHEMBL11368899 0.92 PTGS2 (0.58) PTGS2TTRPTGS1CXCL8ABCB11
SCHEMBL8956861 0.92 PTGS2 (0.72) PTGS2TTRPTGS1CXCL8ABCB11
Eltenac SCHEMBL11377896 0.90 PTGS2 (0.55) PTGS2TTRPTGS1CXCL8ABCB11
SCHEMBL14445015 0.87 PTGS2 (0.50) PTGS2TTRPTGS1CXCL8ABCB11
SCHEMBL11348348 0.87 PTGS2 (0.50) PTGS2TTRPTGS1CXCL8ABCB11
Eltenac SCHEMBL11368803 0.86 PTGS2 (0.68) PTGS2TTRPTGS1CXCL8ABCB11
SCHEMBL11347865 0.86 CXCL8 (0.55) PTGS2TTRPTGS1CXCL8ABCB11
SCHEMBL11346658 0.85 PTGS2 (0.59) PTGS2TTRPTGS1CXCL8ABCB11
SCHEMBL11346220 0.85 CXCL8 (0.70) PTGS2TTRPTGS1CXCL8ABCB11
SCHEMBL11366136 0.85 TTR (0.50) PTGS2TTRPTGS1CXCL8ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 846 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752201-B1 SUSPENSION OF NANOSCALE, ORGANIC PARTICLES AND PROCESS FOR PRODUCTION THEREOF UNIV FRIEDRICH ALEXANDER ER (DE) 2023-11-22 EP claimed
EP-3998932-A1 ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS Parsons, C. Lowell (US) 2022-05-25 EP claimed
WO-2021011566-A1 ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS PARSONS C LOWELL (US) 2021-01-21 WO claimed
EP-3752201-A1 SUSPENSION OF NANOSCALE, ORGANIC PARTICLES AND PROCESS FOR PRODUCTION THEREOF Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2020-12-23 EP claimed
EP-3609483-A1 ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY Urigen Pharmaceuticals, Inc. (US) 2020-02-19 EP claimed
WO-2019158509-A1 SUSPENSION OF NANOSCALE, ORGANIC PARTICLES AND PROCESS FOR PRODUCTION THEREOF Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2019-08-22 WO claimed
WO-2018191412-A9 ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY URIGEN PHARMACEUTICALS, INC. (US) 2019-05-31 WO claimed
WO-2018191412-A1 ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY URIGEN PHARMACEUTICALS, INC. (US) 2018-10-18 WO claimed
US-9180249-B2 Method and device BIMEDA RESEARCH & DEVELOPMENT LIMITED (IE) 2015-11-10 US claimed
US-9161927-B2 Drug combinations containing PDE4 inhibitors and NSAIDs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-20 US claimed
US-20050171506-A1 Method and device ZOETIS BROOMHILL IP LIMITED (IE) 2005-08-04 US claimed
US-6858223-B2 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) ALTANA PHARMA AG (DE) 2005-02-22 US claimed
US-20040242597-A1 Combination NYCOMED GMBH (DE) 2004-12-02 US claimed
WO-2004071391-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA PHARMA AG (DE) 2004-08-26 WO claimed
EP-1429807-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA Pharma AG (DE) 2004-06-23 EP claimed
EP-1336602-A1 Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases Scaramuzzino, Giovanni (IT) 2003-08-20 EP claimed
WO-2003024489-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA PHARMA AG (DE) 2003-03-27 WO claimed
EP-1098645-B1 COMPOSITIONS COMPRISING PHENYLAMINOTHIOPHENACETIC ACID DERIVATIVES FOR THE TREATMENT OF ACUTE OR ADULT RESPIRATORY DISTRESS SYNDROME (ARDS) AND INFANT RESPIRATORY DISTRESS SYNDROME (IRDS) ALTANA PHARMA AG (DE) 2002-11-20 EP claimed
EP-0005559-B1 PHENYLAMINOTHIOPHENE ACETIC ACIDS, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1981-11-04 EP claimed
US-4272507-A Phenylaminothiophenacetic acids, their synthesis, compositions and use BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1981-06-09 US claimed